PLRZ (Polyrizon) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 02, 2026)


PLRZ Polyrizon Ltd PLRZ
14 GF Score
Price $12.61
! 4 Warning Signs
View Full Analysis

What is Polyrizon Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Polyrizon's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

PLRZ vs SKYE, NEUP, LGVN: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Polyrizon's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Polyrizon Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Polyrizon's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Polyrizon's Margin of Safety % (DCF Earnings Based) falls into.


PLRZ
14GF Score
Polyrizon Ltd PLRZ
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Polyrizon Business Description

Address 5 Ha-Tidhar Street, Raanana, ISR, 4366507
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
14GF Score

Get the complete analysis for PLRZ

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.61
Price